实现新冠病毒疫苗的潜力——机会渺茫？ - Suppr

Suppr

超能文献

Realising the potential of SARS-CoV-2 vaccines-a long shot?

出版信息

Lancet Respir Med. 2021 Feb;9(2):117. doi: 10.1016/S2213-2600(21)00045-X. Epub 2021 Jan 20.

DOI:10.1016/S2213-2600(21)00045-X

PMID:33484632

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7817463/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a89a/7817463/88ed67b25ed6/fx1_lrg.jpg

相似文献

Realising the potential of SARS-CoV-2 vaccines-a long shot?实现新冠病毒疫苗的潜力——机会渺茫？

Lancet Respir Med. 2021 Feb;9(2):117. doi: 10.1016/S2213-2600(21)00045-X. Epub 2021 Jan 20.

Novavax offers first evidence that COVID vaccines protect people against variants.诺瓦瓦克斯公司提供了首个证据，证明新冠疫苗可保护人们抵御病毒变种。

Nature. 2021 Feb;590(7844):17. doi: 10.1038/d41586-021-00268-9.

COVID vaccines slash viral spread - but Delta is an unknown.新冠疫苗大幅减少病毒传播——但德尔塔毒株情况不明。

Nature. 2021 Aug;596(7870):17-18. doi: 10.1038/d41586-021-02054-z.

Covid mutations: honest approach needed from politicians and scientists on pandemic outlook.新冠病毒变异：政治家和科学家需以坦诚态度面对疫情前景

BMJ. 2021 Mar 9;372:n656. doi: 10.1136/bmj.n656.

COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.大流行期间的COVID-19演变——新型SARS-CoV-2变体对疾病控制和公共卫生政策的影响。

Virulence. 2021 Dec;12(1):507-508. doi: 10.1080/21505594.2021.1877066.

COVID-19 human challenge studies in the UK.英国的新冠病毒人体挑战研究。

Lancet Respir Med. 2020 Dec;8(12):e96. doi: 10.1016/S2213-2600(20)30518-X. Epub 2020 Oct 30.

UK science advisers: publish evidence behind COVID vaccine changes.英国科学顾问：公布新冠疫苗变更背后的证据。

Nature. 2021 Jan;589(7841):169-170. doi: 10.1038/d41586-021-00045-8.

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。

MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.

Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2.灭活新冠疫苗BBV152/COVAXIN可有效中和最近出现的新冠病毒B.1.1.7变异株。

J Travel Med. 2021 Jun 1;28(4). doi: 10.1093/jtm/taab051.

What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.科学家们对牛津大学-阿斯利康新冠疫苗了解和不了解的情况。

Nature. 2021 Apr;592(7852):15-17. doi: 10.1038/d41586-021-00785-7.

引用本文的文献

SARS-CoV-2 Seroepidemiological Investigation in Jordan: Seroprevalence, Herd Immunity, and Vaccination Coverage. A Population-Based National Study.约旦的新冠病毒血清流行病学调查：血清阳性率、群体免疫和疫苗接种覆盖率。一项基于人群的全国性研究。

Int J Gen Med. 2022 Sep 5;15:7053-7062. doi: 10.2147/IJGM.S371711. eCollection 2022.

Impact of Microbiota Depletion by Antibiotics on SARS-CoV-2 Infection of K18-hACE2 Mice.抗生素对 K18-hACE2 小鼠 SARS-CoV-2 感染的微生物组耗竭的影响。

Cells. 2022 Aug 18;11(16):2572. doi: 10.3390/cells11162572.

SARS-CoV-2 seroprevalence in the city of Puerto Madryn: Underdiagnosis and relevance of children in the pandemic.阿根廷马尔维纳斯省蓬塔马德拉市的 2019 冠状病毒病血清流行率：漏诊和儿童在大流行中的相关性。

PLoS One. 2022 Mar 14;17(3):e0263679. doi: 10.1371/journal.pone.0263679. eCollection 2022.

Effects of vaccination and non-pharmaceutical interventions and their lag times on the COVID-19 pandemic: Comparison of eight countries.疫苗接种和非药物干预措施及其时滞对 COVID-19 大流行的影响：八个国家的比较。

PLoS Negl Trop Dis. 2022 Jan 13;16(1):e0010101. doi: 10.1371/journal.pntd.0010101. eCollection 2022 Jan.

Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.SARS-CoV-2 衍生合成长肽的选择和 T 细胞抗原性。

J Gen Virol. 2022 Jan;103(1). doi: 10.1099/jgv.0.001698.

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview.基于RNA的疫苗在抗击新冠疫情中的重要性：概述

Vaccines (Basel). 2021 Nov 17;9(11):1345. doi: 10.3390/vaccines9111345.

Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential.肠道微生物组在 COVID-19 中的作用：对发病机制和治疗潜力的深入了解。

Front Immunol. 2021 Oct 14;12:765965. doi: 10.3389/fimmu.2021.765965. eCollection 2021.

Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age.长期的新冠病毒特异性免疫受初始新冠疫情严重程度和患者年龄的影响。

J Clin Med. 2021 Oct 8;10(19):4606. doi: 10.3390/jcm10194606.

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany.基于德国波恩的一项人群研究的 SARS-CoV-2 中和抗体的血清阳性率和相关因素。

Nat Commun. 2021 Apr 9;12(1):2117. doi: 10.1038/s41467-021-22351-5.

COVID-19: Filling the Many Knowledge Gaps and Supporting Evidence-Based Vaccination.2019冠状病毒病：填补诸多知识空白并支持基于证据的疫苗接种

J Pharm Pract Res. 2021 Feb;51(1):4-6. doi: 10.1002/jppr.1717. Epub 2021 Feb 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验